Rankings
▼
Calendar
NVAX Q3 2018 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena
NVAX
Novavax, Inc.
$2B
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
-7.4% YoY
Gross Profit
$8M
100.0% margin
Operating Income
-$42M
-541.7% margin
Net Income
-$45M
-576.2% margin
EPS (Diluted)
$-2.33
QoQ Revenue Growth
-28.2%
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$34M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$250M
Total Liabilities
$377M
Stockholders' Equity
-$127M
Cash & Equivalents
$56M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$8M
-7.4%
Gross Profit
$8M
$8M
-7.4%
Operating Income
-$42M
-$42M
-0.7%
Net Income
-$45M
-$45M
+0.1%
← FY 2018
All Quarters
Q4 2018 →